Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07023822 · ClinicalTrials.gov registry record · NA
WISH, Feasibility of a Factorial Design
A NA study of Breast Cancer and Body Image, sponsored by The University of Tennessee, Knoxville.
- Active
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT07023822 is a NA study of Breast Cancer and Body Image that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 18 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07023822, a NA study of Breast Cancer and Body Image, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to evaluate the feasibility of testing a multi-component intervention for sexual function using a factorial design.
Conditions Studied
Interventions
- DEVICE Hyaluronic acid (HLA) Vaginal Moisturizer
- DEVICE Polycarbophil Vaginal Moisturizer
- BEHAVIORAL Hypnotic Relaxation
- BEHAVIORAL Progressive Muscle Relaxation (PMR)
Study Locations (1)
Tennessee
- University of Tennessee, College of Nursing - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2025-06-16 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07023822
The ClinicalTrials.gov registry entry for NCT07023822 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is The University of Tennessee, Knoxville, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Hyaluronic acid (HLA) Vaginal Moisturizer is the first listed.
NCT07023822 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT07023822 about?
NCT07023822 is a clinical study titled "WISH, Feasibility of a Factorial Design". The primary aim of this study is to evaluate the feasibility of testing a multi-component intervention for sexual function using a factorial design.
What is the current status of trial NCT07023822?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-06-16. Estimated completion is 2025-09-30.
What conditions does trial NCT07023822 study?
This clinical trial studies the following conditions: Breast Cancer, Body Image, Vulvovaginal Signs and Symptoms, Sexual Desire Disorder.
What interventions are being tested in trial NCT07023822?
The interventions under investigation include: Hyaluronic acid (HLA) Vaginal Moisturizer (DEVICE), Polycarbophil Vaginal Moisturizer (DEVICE), Hypnotic Relaxation (BEHAVIORAL), Progressive Muscle Relaxation (PMR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07023822?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07023822 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.